Analogic Co. (ALOG) Position Cut by Two Sigma Investments LP

Two Sigma Investments LP decreased its position in Analogic Co. (NASDAQ:ALOG) by 13.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 56,345 shares of the medical research company’s stock after selling 8,472 shares during the period. Two Sigma Investments LP owned approximately 0.45% of Analogic worth $4,719,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Acadian Asset Management LLC bought a new stake in Analogic in the fourth quarter valued at $3,102,000. Bank of Montreal Can increased its stake in Analogic by 37.6% in the fourth quarter. Bank of Montreal Can now owns 52,237 shares of the medical research company’s stock valued at $4,375,000 after purchasing an additional 14,280 shares in the last quarter. Ameriprise Financial Inc. increased its stake in Analogic by 10.6% in the third quarter. Ameriprise Financial Inc. now owns 354,655 shares of the medical research company’s stock valued at $29,703,000 after purchasing an additional 34,021 shares in the last quarter. Legal & General Group Plc increased its stake in Analogic by 6.8% in the third quarter. Legal & General Group Plc now owns 25,362 shares of the medical research company’s stock valued at $2,125,000 after purchasing an additional 1,613 shares in the last quarter. Finally, Pinebridge Investments L.P. increased its stake in Analogic by 58.1% in the fourth quarter. Pinebridge Investments L.P. now owns 18,179 shares of the medical research company’s stock valued at $1,523,000 after purchasing an additional 6,681 shares in the last quarter. Institutional investors and hedge funds own 97.55% of the company’s stock.

Shares of Analogic stock opened at $91.60 on Friday. Analogic Co. has a 52 week low of $66.00 and a 52 week high of $101.80. The firm has a market cap of $1,145.09, a price-to-earnings ratio of -15.82, a price-to-earnings-growth ratio of 3.09 and a beta of 0.77.

Analogic (NASDAQ:ALOG) last posted its quarterly earnings results on Monday, March 5th. The medical research company reported $1.27 earnings per share for the quarter, beating the consensus estimate of $0.69 by $0.58. Analogic had a negative net margin of 15.34% and a positive return on equity of 6.05%. The firm had revenue of $129.20 million during the quarter, compared to the consensus estimate of $112.50 million. During the same period in the previous year, the firm posted $0.99 earnings per share. The business’s revenue was down 1.7% compared to the same quarter last year. equities analysts predict that Analogic Co. will post 4.23 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 26th. Stockholders of record on Thursday, March 15th will be given a dividend of $0.10 per share. This represents a $0.40 annualized dividend and a dividend yield of 0.44%. The ex-dividend date is Wednesday, March 14th. Analogic’s payout ratio is presently -6.91%.

ALOG has been the subject of several research analyst reports. BidaskClub downgraded shares of Analogic from a “hold” rating to a “sell” rating in a research note on Thursday, December 7th. Jefferies Group reaffirmed a “hold” rating and issued a $80.00 price target on shares of Analogic in a research note on Friday, December 8th. Finally, Zacks Investment Research raised shares of Analogic from a “hold” rating to a “buy” rating and set a $97.00 price target for the company in a research note on Friday, December 8th.

TRADEMARK VIOLATION NOTICE: “Analogic Co. (ALOG) Position Cut by Two Sigma Investments LP” was originally reported by Ticker Report and is the sole property of of Ticker Report. If you are reading this report on another publication, it was stolen and reposted in violation of United States and international copyright and trademark laws. The correct version of this report can be viewed at https://www.tickerreport.com/banking-finance/3299647/analogic-co-alog-position-cut-by-two-sigma-investments-lp.html.

Analogic Profile

Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies. The Company operates through three segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography.

Want to see what other hedge funds are holding ALOG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Analogic Co. (NASDAQ:ALOG).

Institutional Ownership by Quarter for Analogic (NASDAQ:ALOG)

Receive News & Ratings for Analogic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Analogic and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Slothcoin  One Day Volume Hits $4,181.00
Slothcoin One Day Volume Hits $4,181.00
YEE  Price Up 12.9% Over Last 7 Days
YEE Price Up 12.9% Over Last 7 Days
Lakeland Industries  Given Average Rating of “Strong Buy” by Brokerages
Lakeland Industries Given Average Rating of “Strong Buy” by Brokerages
Zacks: Analysts Anticipate Ares Management  Will Announce Quarterly Sales of $198.50 Million
Zacks: Analysts Anticipate Ares Management Will Announce Quarterly Sales of $198.50 Million
Ascent Capital Group  Expected to Announce Quarterly Sales of $133.40 Million
Ascent Capital Group Expected to Announce Quarterly Sales of $133.40 Million
First Cash Financial Services  Releases Quarterly  Earnings Results, Beats Estimates By $0.15 EPS
First Cash Financial Services Releases Quarterly Earnings Results, Beats Estimates By $0.15 EPS


© 2006-2018 Ticker Report. Google+.